Drag a card by its title · ⚙ to size, swap or remove

The company

Kiniksa Pharmaceuticals International, plc - Class A

KNSA · Nasdaq

Health CareBiotechnologyLeading

KNSA stood above a rising 150-day average in 52 of the last 52 weekly readings, every one of them. It is 26.2% above that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Leading
Weeks in an uptrend: 52 in a row
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $93.5M
Officials’ trades on record: 0
Institutions holding: 254 (+36)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 52 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months32

Buyers · sellers0 · 8

Who	Did	Shares	Traded
Michael R. MegnaCHIEF ACCOUNTING OFFICER	sold	4,600at $80.30	3 Sep 2026filed 3 Sep 2026
G. Bradley ColeDirector	sold	3,673at $81.43	29 Jul 2026filed 31 Jul 2026
Sanj K. PatelCHAIRMAN & CEO	sold	48,565at $54.02	1 May 2026filed 1 May 2026
John F. PaoliniCHIEF MEDICAL OFFICER	sold	37,327at $53.52	1 May 2026filed 5 May 2026
John F. PaoliniCHIEF MEDICAL OFFICER	sold	21,097at $54.04	1 May 2026filed 5 May 2026
Sanj K. PatelCHAIRMAN & CEO	sold	2,141at $54.01	30 Apr 2026filed 30 Apr 2026
Sanj K. PatelCHAIRMAN & CEO	sold	22,544at $54.01	29 Apr 2026filed 30 Apr 2026
Barry D. QuartDirector	sold	13,099at $50.10	28 Apr 2026filed 29 Apr 2026
Sanj K. PatelCHAIRMAN & CEO	sold	74,635at $50.43	28 Apr 2026filed 30 Apr 2026
Sanj K. PatelCHAIRMAN & CEO	sold	113,673at $51.47	28 Apr 2026filed 30 Apr 2026
Sanj K. PatelCHAIRMAN & CEO	sold	243,596at $52.02	28 Apr 2026filed 30 Apr 2026
Sanj K. PatelCHAIRMAN & CEO	sold	51,750at $54.02	28 Apr 2026filed 30 Apr 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders254+36 on the quarter

New · exited69 · 32

Reported value$2.9B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
FMR LLCadded · filed 13 Aug 2026	6,971,361$445.8M	+147,661+2.2%
Rubric Capital Management LPadded · filed 14 Aug 2026	3,999,800$255.8M	+249,800+6.7%
BAKER BROS. ADVISORS LPadded · filed 14 Aug 2026	2,834,643$181.3M	+8,397+0.3%
BlackRock, Inc.added · filed 7 Aug 2026	2,739,615$175.2M	+2,252,878+462.9%
TANG CAPITAL MANAGEMENT LLCunchanged · filed 14 Aug 2026	2,259,889$144.5M	00.0%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026	1,911,335$122.2M	+145,067+8.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	1,360,840$87.0M	+27,747+2.1%
MORGAN STANLEYadded · filed 13 Aug 2026	1,011,143$64.7M	+13,357+1.3%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPadded · filed 13 Aug 2026	957,514$61.2M	+64,848+7.3%
Spruce Street Capital LPadded · filed 13 Aug 2026	918,070$58.7M	+157,007+20.6%